Diagnosing, Treating, and Managing Scleritis in 2020
The live program has concluded.
If you attended, please click on the "Take Post-Test" button to claim your credit. If you did not attend, please stay tuned for the archived version, which will be available soon for on-demand viewing.
Overview
This work is based on a virtual roundtable discussion hosted by Evolve Medical Education LLC. Although uncommon, scleritis is a dangerous immune-mediated disease that can potentially threaten the structural integrity of the eye and may be indicative of potentially life-threatening systemic vasculitis. Data on the genetic factors of scleritis is lacking, but it is thought that genes affecting systemic autoimmune diseases impact scleritis as well. Differentiating between episcleritis and scleritis and posterior and anterior scleritis can be challenging for physicians. An accurate diagnosis is critical to properly treat the disease and prevent vision loss. In the following summary of a roundtable discussion, experts comment on the complexity in diagnosing scleritis, compare the efficacy of therapeutics based on patient presentation, and review treatment plans for patients who are refractory or nonresponders. This work was supported by an unrestricted medical writing grant from Mallinckrodt Pharmaceuticals. Faculty and Disclosures
DISCLOSURE POLICY
MELISSA TOYOS, MD Partner and Director of Research Toyos Clinic Nashville, TN THOMAS A. ALBINI, MD Professor of Clinical Ophthalmology University of Miami Health Bascom Palmer Eye Institute Miami, FL STEPHEN D. ANESI, MD, FACS Massachusetts Eye Research & Surgery Institution Waltham, MA DAVID S. CHU, MD Medical Director, Metropolitan Eye Research & Surgery Institute Associate Professor of Clinical Ophthalmology Rutgers University Newark, NJ ROBERT C. WANG, MD Texas Retina Associates Dallas, TX
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
- Apple Safari for Mac OS and iOS
- Mozilla Firefox for Windows, Mac OS, iOS, and Android
- Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- CME/CE Broadcast Replay
Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
1.00 credit
Deepak Sambhara, MD
